Latest Articles

Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and progressing understanding of existing drugs.

High demand and supply shortages of weight loss drugs have presented opportunities for counterfeit drugs to enter the market. So, what are the dangers of counterfeits? And what can consumers look out for?

Incretin-mimetic drugs contribute to dramatic weight loss, but this does not solely mean fat loss. In this article, we explore the impact of incretin-mimetic drugs on muscle health and what can be done to limit these severe side effects.

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the prevention of HIV, but also for other rapidly mutating viruses such as influenza and SARS-CoV-2.

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global markets and the innovative technologies shaping the future of pharmaceutical development.

Jakub Vašíček joined us to discuss a new bioinformatic tool – ProHap – a Python-based tool that creates custom protein sequence databases from large panels of reference human haplotypes.

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

The use of human liver microtissues (hLiMTs) cultured in a 384-well microplate system was explored as a predictive model for assessing drug-induced liver injury (DILI) with promising results.

Impurities in pharmaceuticals are a major concern for drug manufacturers. This article will discuss the importance of monitoring and minimizing impurities in drug substances and products and key developments in the field.

This article examines some of the latest advances in biomarker discovery in the fields of cancer and neurodegenerative and infectious diseases and the technologies that are driving these discoveries.